| Nome |
# |
|
Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19, file d85263f2-9548-4fd3-882d-90fbcf198e12
|
191
|
|
Diurnal mouthpiece ventilation and nocturnal non-invasive ventilation versus tracheostomy invasive ventilation in patients with amyotrophic lateral sclerosis., file e268c4cc-9b51-a6b7-e053-3a05fe0adea1
|
169
|
|
LABA/LAMA fixed-dose combinations in patients with COPD: a systematic review., file e268c4ca-4cb2-a6b7-e053-3a05fe0adea1
|
120
|
|
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma, file e268c4ca-bf38-a6b7-e053-3a05fe0adea1
|
110
|
|
MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence, file e268c4ca-971c-a6b7-e053-3a05fe0adea1
|
106
|
|
Cost-description and multiple imputation of missing values: the SATisfaction and adherence to COPD treatment (SAT) study, file e268c4cb-87d8-a6b7-e053-3a05fe0adea1
|
105
|
|
Patients beliefs on intravenous and subcutaneous routes of administration of biologics for severe asthma treatment: A cross-sectional observational survey study, file e268c4cb-1dc3-a6b7-e053-3a05fe0adea1
|
101
|
|
Disease awareness in patients with COPD: measurement and extent, file e268c4ca-1c31-a6b7-e053-3a05fe0adea1
|
87
|
|
The unmet need for pertussis prevention in patients with chronic obstructive pulmonary disease in the Italian context, file e268c4ca-9b27-a6b7-e053-3a05fe0adea1
|
82
|
|
Commentary on "Costs of pharmacotherapy of chronic obstructive pulmonary disease in relation to changing Global Initiative for Chronic Obstructive Lung Disease guidelines (2007, 2011, and 2017 updates)", file e268c4ca-6848-a6b7-e053-3a05fe0adea1
|
81
|
|
Chronic obstructive lung disease “expert system”: Validation of a predictive tool for assisting diagnosis, file e268c4ca-baaf-a6b7-e053-3a05fe0adea1
|
73
|
|
Satisfaction with chronic obstructive pulmonary disease treatment: results from a multicenter, observational study, file e268c4cb-dfab-a6b7-e053-3a05fe0adea1
|
72
|
|
The perception of Obstructive Sleep Apnoea/Hypopnoea Syndrome (OSAHS) among Italian general practitioners, file e268c4ca-b970-a6b7-e053-3a05fe0adea1
|
68
|
|
Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN), file e268c4ca-fb38-a6b7-e053-3a05fe0adea1
|
67
|
|
Impact of reslizumab on outcomes of severe asthmatic patients: current perspectives, file e268c4ca-bdd5-a6b7-e053-3a05fe0adea1
|
66
|
|
The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: the results of a double blind, placebo controlled, multicenter clinical trial, file e268c4c6-b786-a6b7-e053-3a05fe0adea1
|
64
|
|
Severe T2-high asthma in the biologics era: European experts' opinion, file e268c4ca-24fe-a6b7-e053-3a05fe0adea1
|
60
|
|
Symptom variability and control in COPD: Advantages of dual bronchodilation therapy, file e268c4cd-15d9-a6b7-e053-3a05fe0adea1
|
60
|
|
Determinants and impact of suboptimal asthma control in Europe: The INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study, file e268c4ca-92af-a6b7-e053-3a05fe0adea1
|
59
|
|
Pidotimod: The state of art, file e268c4ca-b975-a6b7-e053-3a05fe0adea1
|
56
|
|
Effects of aclidinium on determinants of COPD severity: Symptoms and quality of life, file e268c4ca-be55-a6b7-e053-3a05fe0adea1
|
56
|
|
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle, file e268c4ca-cb56-a6b7-e053-3a05fe0adea1
|
56
|
|
Mobile technology in allergic rhinitis: evolution in management or revolution in health and care?, file e268c4ca-f0c7-a6b7-e053-3a05fe0adea1
|
56
|
|
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis, file e268c4cc-b23b-a6b7-e053-3a05fe0adea1
|
56
|
|
Psychological aspects in asthma: Do psychological factors affect asthma management?, file e268c4ca-d45f-a6b7-e053-3a05fe0adea1
|
54
|
|
Transoral glossoepiglottopexy in the treatment of adult obstructive sleep apnoea: A surgical approach
[Glossoepiglottoplastica con approccio trans-orale nel trattamento delle apnee ostruttive notturne nell’adulto], file e268c4ca-ab8b-a6b7-e053-3a05fe0adea1
|
53
|
|
The Portuguese version of Rhinitis and Asthma Patient's Perspective (RAPP): Validation and assessment, file e268c4cd-d068-a6b7-e053-3a05fe0adea1
|
53
|
|
'Emergency exit' of bone-marrow-resident CD34+ DNAM-1 bright CXCR4+-committed lymphoid precursors during chronic infection and inflammation, file e268c4ca-596c-a6b7-e053-3a05fe0adea1
|
52
|
|
A Framework For Step Down Or Therapeutic Re-Organization For Withdrawal Of Inhaled Corticosteroids In Selected Patients With COPD: A Proposal For COPD Management, file e268c4ca-a841-a6b7-e053-3a05fe0adea1
|
51
|
|
"Trying, But Failing" - The Role of Inhaler Technique and Mode of Delivery in Respiratory Medication Adherence, file e268c4cc-05c9-a6b7-e053-3a05fe0adea1
|
47
|
|
Neuropsychiatric Disorders and Frailty in Older Adults over the Spectrum of Cancer: A Narrative Review, file e268c4ce-3781-a6b7-e053-3a05fe0adea1
|
36
|
|
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy, file e268c4cc-c929-a6b7-e053-3a05fe0adea1
|
25
|
|
null, file e268c4ca-ed2f-a6b7-e053-3a05fe0adea1
|
17
|
|
Is diet partly responsible for differences in COVID-19 death rates between and within countries?, file e268c4cd-3e2f-a6b7-e053-3a05fe0adea1
|
12
|
|
Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19, file e268c4cc-cdbb-a6b7-e053-3a05fe0adea1
|
10
|
|
null, file e268c4cd-7625-a6b7-e053-3a05fe0adea1
|
8
|
|
Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0), file e268c4ce-60ab-a6b7-e053-3a05fe0adea1
|
7
|
|
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy, file f2e2c9fe-0015-4107-81ef-fb915010dffd
|
6
|
|
Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air® App, file e268c4cc-e48e-a6b7-e053-3a05fe0adea1
|
5
|
|
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19, file e268c4cf-0177-a6b7-e053-3a05fe0adea1
|
4
|
|
null, file e268c4ca-2553-a6b7-e053-3a05fe0adea1
|
3
|
|
Umeclidinium for the treatment of uncontrolled asthma, file e268c4ca-be5b-a6b7-e053-3a05fe0adea1
|
3
|
|
Biosimilars in allergic diseases, file e268c4ca-f702-a6b7-e053-3a05fe0adea1
|
3
|
|
Kidney disease and all-cause mortality in patients with COVID-19 hospitalized in Genoa, Northern Italy, file 289f0df2-993e-441f-8b16-3d0cac2a001d
|
2
|
|
Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies, file 5863516d-ea73-4e4b-a554-9c9ddd692662
|
2
|
|
Disability in COPD and its relationship to clinical and patient-reported outcomes, file e268c4c6-0df3-a6b7-e053-3a05fe0adea1
|
2
|
|
null, file e268c4ca-af17-a6b7-e053-3a05fe0adea1
|
2
|
|
Do Asthmatic Patients and Their Physicians Agree on the Presence and Severity of Allergic Rhinitis?, file e268c4ca-b972-a6b7-e053-3a05fe0adea1
|
2
|
|
Sleep complaints and sleep breathing disorders in upper and lower obstructive lung diseases, file e268c4ca-bc18-a6b7-e053-3a05fe0adea1
|
2
|
|
Adherence to treatment and monitoring tools: what's new?, file e268c4ca-d896-a6b7-e053-3a05fe0adea1
|
2
|
|
Latex allergy and occupational exposure: The patient’s perspective, file e268c4ca-fe9c-a6b7-e053-3a05fe0adea1
|
2
|
|
Medical devices in allergy practice, file e268c4cc-dc6f-a6b7-e053-3a05fe0adea1
|
2
|
|
Withdrawal of inhaled corticosteroids in COPD: A meta-analysis, file e268c4cd-294e-a6b7-e053-3a05fe0adea1
|
2
|
|
Manifesto on united airways diseases (UAD): an Interasma (global asthma association - GAA) document, file e268c4ce-878e-a6b7-e053-3a05fe0adea1
|
2
|
|
Quick Olfactory Sniffin’ Sticks Test (Q-Sticks) for the detection of smell disorders in COVID-19 patients, file 12acfdd0-2da7-4c27-aa9c-cdb49471d6f7
|
1
|
|
The cross-cultural validation of the English version of RhinAsthma patient's perspective (RAPP), file e268c4ca-46c9-a6b7-e053-3a05fe0adea1
|
1
|
|
CD4+CD25highCD127- regulatory T-cells in COPD: Smoke and drugs effect, file e268c4ca-4ad0-a6b7-e053-3a05fe0adea1
|
1
|
|
Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical Practice, file e268c4ca-4e8a-a6b7-e053-3a05fe0adea1
|
1
|
|
High flow nasal cannula oxygen therapy, work in progress in respiratory critical care, file e268c4ca-92ab-a6b7-e053-3a05fe0adea1
|
1
|
|
Clinical and Functional Characteristics of COPD Patients Across GOLD Classifications: Results of a Multicenter Observational Study, file e268c4ca-9793-a6b7-e053-3a05fe0adea1
|
1
|
|
Use of ICS in COPD: From Blockbuster Medicine to Precision Medicine, file e268c4ca-a83d-a6b7-e053-3a05fe0adea1
|
1
|
|
Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement, file e268c4ca-a990-a6b7-e053-3a05fe0adea1
|
1
|
|
Mechanical bacterial lysate administration prevents exacerbation in allergic asthmatic children—The EOLIA study, file e268c4ca-ab8d-a6b7-e053-3a05fe0adea1
|
1
|
|
Sub-lingual administration of a polyvalent mechanical bacterial lysate (PMBL) in patients with moderate, severe, or very severe chronic obstructive pulmonary disease (COPD) according to the GOLD spirometric classification: A multicentre, double-blind, randomised, controlled, phase IV study (AIACE study: Advanced Immunological Approach in COPD Exacerbation), file e268c4ca-ab8f-a6b7-e053-3a05fe0adea1
|
1
|
|
Patient-reported outcomes in asthma clinical trials, file e268c4ca-ad5f-a6b7-e053-3a05fe0adea1
|
1
|
|
RhinAsthma patient perspective: A Rasch validation study, file e268c4ca-ae78-a6b7-e053-3a05fe0adea1
|
1
|
|
Genuair® Usability Test: Results of a National Public Survey of the Elderly, file e268c4ca-ae85-a6b7-e053-3a05fe0adea1
|
1
|
|
Anxiety and depression in cystic fibrosis, file e268c4ca-b7ab-a6b7-e053-3a05fe0adea1
|
1
|
|
Choosing wisely: Practical considerations on treatment efficacy and safety of asthma in the elderly, file e268c4ca-b7b2-a6b7-e053-3a05fe0adea1
|
1
|
|
Minimal clinical important difference (MCID) of the Thai chronic urticaria quality of life questionnaire (CU-Q2oL), file e268c4ca-b977-a6b7-e053-3a05fe0adea1
|
1
|
|
Quality-of-life issues in survivors to anaphylactic reactions to drugs, file e268c4ca-bc20-a6b7-e053-3a05fe0adea1
|
1
|
|
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey, file e268c4ca-be51-a6b7-e053-3a05fe0adea1
|
1
|
|
Switching treatments in COPD: Implications for costs and treatment adherence, file e268c4ca-cb5d-a6b7-e053-3a05fe0adea1
|
1
|
|
Public awareness on cystic fibrosis: Results from a national pragmatic survey, file e268c4ca-cf8b-a6b7-e053-3a05fe0adea1
|
1
|
|
Disability in moderate chronic obstructive pulmonary disease: Prevalence, burden and assessment-results from a real-life study, file e268c4ca-cf8f-a6b7-e053-3a05fe0adea1
|
1
|
|
Improving donor lung suitability: from protective strategies to ex-vivo reconditioning, file e268c4ca-d893-a6b7-e053-3a05fe0adea1
|
1
|
|
Choose your outcomes: From the mean to the personalized assessment of outcomes in COPD. An exploratory pragmatic survey, file e268c4ca-e37e-a6b7-e053-3a05fe0adea1
|
1
|
|
Phenotypes/endotypes-driven treatment in asthma, file e268c4ca-ec36-a6b7-e053-3a05fe0adea1
|
1
|
|
Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)(Clin Transl Allergy (2016) 6 (29) DOI: 10.1186/s13601-016-0116-9), file e268c4ca-f400-a6b7-e053-3a05fe0adea1
|
1
|
|
Routine Use of Budesonide/Formoterol Fixed Dose Combination in Elderly Asthmatic Patients: Practical Considerations, file e268c4ca-f404-a6b7-e053-3a05fe0adea1
|
1
|
|
RHINASTHMA-Children: A new quality of life tool for patients with respiratory allergy, file e268c4ca-f6ec-a6b7-e053-3a05fe0adea1
|
1
|
|
Patient-physician relationship in the management of asthma: Multicentric approach in Latin America, file e268c4ca-fb3c-a6b7-e053-3a05fe0adea1
|
1
|
|
No indication for right heart catheterisation for patients with isolated severe obstructive sleep apnoea syndrome according to a guideline-recommended approach, file e268c4cb-035b-a6b7-e053-3a05fe0adea1
|
1
|
|
Non-invasive ventilation in acute respiratory failure of patients with obesity hypoventilation syndrome, file e268c4cb-91dd-a6b7-e053-3a05fe0adea1
|
1
|
|
Quality standards for the management of bronchiectasis in Italy: A national audit, file e268c4cb-ae4c-a6b7-e053-3a05fe0adea1
|
1
|
|
LABA/LAMA Fixed Dose Combination in Chronic Obstructive Pulmonary Disease: The Impact on Health-Related Quality of Life, file e268c4cc-235f-a6b7-e053-3a05fe0adea1
|
1
|
|
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation, file e268c4cc-967f-a6b7-e053-3a05fe0adea1
|
1
|
|
What to consider before prescribing inhaled medications: a pragmatic approach for evaluating the current inhaler landscape, file e268c4cc-dceb-a6b7-e053-3a05fe0adea1
|
1
|
|
Clinically significant differences in patient-reported outcomes evaluations in chronic spontaneous urticaria, file e268c4cc-e2fd-a6b7-e053-3a05fe0adea1
|
1
|
|
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity, file e268c4cd-c3e1-a6b7-e053-3a05fe0adea1
|
1
|
| Totale |
2.528 |